FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| LY-195448, 111974-80-2, LY-195448 Intermediate 1330753-72-4, stock 116.7g, white powder, assay by HPLC 98.8%, HNMR, LCMS we supply. |
| LY-195448, 111974-80-2, LY-195448 Intermediate /, stock 878.5g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply. |
| LY-195448, 111974-80-2, LY-195448 Intermediate 80051-06-5, stock 502.2g, white powder, assay by HPLC 99.2%, HNMR, LCMS we supply. |
| LY-195448, 111974-80-2, LY-195448 Intermediate /, stock 199.4g, white powder, assay by HPLC 99.6%, HNMR, LCMS we supply. |
| LY-195448, 111974-80-2, LY-195448 Intermediate 74249-19-7, stock 971.3g, white powder, assay by HPLC 99.9%, HNMR, LCMS we supply. |
| LY-195448, 111974-80-2, LY-195448 Intermediate 20780-53-4, stock 886.7g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |
| LY-195448, 111974-80-2, LY-195448 Intermediate 111974-80-2, stock 134.4g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
